| 1 |
33441691 | Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett's esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors. | 2021 Jan 13 |
1 |
| 2 |
31811862 | 12-HETE is a regulator of PGE2 production via COX-2 expression induced by a snake venom group IIA phospholipase A2 in isolated peritoneal macrophages. | 2020 Feb 1 |
1 |
| 3 |
32505122 | THERAPEUTIC TARGETING OF BRAIN ARACHIDONIC ACID CASCADE IN BIPOLAR DISORDER BY LOW DOSE ASPIRIN AND CELECOXIB. | 2020 Aug |
1 |
| 4 |
33016027 | Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy. | 2020 Nov-Dec |
1 |
| 5 |
33038834 | Polyunsaturated fatty acid biosynthesis pathway and genetics. implications for interindividual variability in prothrombotic, inflammatory conditions such as COVID-19✰,✰✰,★,★★. | 2020 Nov |
1 |
| 6 |
30168128 | Integrated eicosanoid lipidomics and gene expression reveal decreased prostaglandin catabolism and increased 5-lipoxygenase expression in aggressive subtypes of endometrial cancer. | 2019 Jan |
1 |
| 7 |
31480263 | Altered Lipid Metabolism in Blood Mononuclear Cells of Psoriatic Patients Indicates Differential Changes in Psoriasis Vulgaris and Psoriatic Arthritis. | 2019 Aug 30 |
1 |
| 8 |
28818745 | A systematic review on the role of eicosanoid pathways in rheumatoid arthritis. | 2018 Mar |
1 |
| 9 |
30429830 | PGE2 Augments Inflammasome Activation and M1 Polarization in Macrophages Infected With Salmonella Typhimurium and Yersinia enterocolitica. | 2018 |
1 |
| 10 |
26677076 | The Lipoxygenases: Their Regulation and Implication in Alzheimer's Disease. | 2016 Feb |
1 |
| 11 |
24976682 | Impact of wines and wine constituents on cyclooxygenase-1, cyclooxygenase-2, and 5-lipoxygenase catalytic activity. | 2014 |
1 |
| 12 |
25369453 | Exogenous addition of arachidonic acid to the culture media enhances the functionality of dendritic cells for their possible use in cancer immunotherapy. | 2014 |
1 |
| 13 |
23398566 | Eicosanoid modulation by the short-chain fatty acid n-butyrate in human monocytes. | 2013 Jul |
2 |
| 14 |
23682075 | Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers. | 2013 Jul |
1 |
| 15 |
23945567 | Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid. | 2013 Nov |
1 |
| 16 |
22891999 | Activation of diverse eicosanoid pathways in osteoarthritic cartilage: a lipidomic and genomic analysis. | 2012 |
2 |
| 17 |
21209362 | Changes in extracellular matrix composition regulate cyclooxygenase-2 expression in human mesangial cells. | 2011 Apr |
2 |
| 18 |
21916491 | 11-Oxoeicosatetraenoic acid is a cyclooxygenase-2/15-hydroxyprostaglandin dehydrogenase-derived antiproliferative eicosanoid. | 2011 Dec 19 |
2 |
| 19 |
20117851 | Dual COXIB/TP antagonists: a possible new twist in NSAID pharmacology and cardiovascular risk. | 2010 Mar |
1 |
| 20 |
20593240 | Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP. | 2010 Dec |
1 |
| 21 |
20840853 | Expression of proliferative and inflammatory markers in a full-thickness human skin equivalent following exposure to the model sulfur mustard vesicant, 2-chloroethyl ethyl sulfide. | 2010 Dec 1 |
1 |
| 22 |
20477063 | Eicosanoids in inflammation and cancer: the role of COX-2. | 2009 Mar |
1 |
| 23 |
17996418 | Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain. | 2008 Mar |
2 |
| 24 |
18812633 | Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man. | 2008 Aug |
2 |
| 25 |
19074288 | Long-chain carboxychromanols, metabolites of vitamin E, are potent inhibitors of cyclooxygenases. | 2008 Dec 23 |
1 |
| 26 |
17305573 | Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers. | 2007 |
2 |
| 27 |
17541796 | Selective COX-2 inhibitors, eicosanoid synthesis and clinical outcomes: a case study of system failure. | 2007 Sep |
1 |
| 28 |
17927497 | Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer. | 2007 |
1 |
| 29 |
17961045 | Are there attacking points in the eicosanoid cascade for chemotherapeutic options in benign meningiomas? | 2007 |
1 |
| 30 |
16760523 | Cyclooxygenase 2 expression in vessels and nerves in reversal reaction leprosy. | 2006 Jun |
1 |
| 31 |
16998585 | Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling. | 2006 Oct |
1 |
| 32 |
15550400 | Cyclooxygenase-2 suppresses hypoxia-induced apoptosis via a combination of direct and indirect inhibition of p53 activity in a human prostate cancer cell line. | 2005 Feb 4 |
1 |
| 33 |
15555528 | The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. | 2005 Jan |
1 |
| 34 |
15618359 | Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system. | 2005 Apr |
2 |
| 35 |
15720401 | Cytosolic phospholipase A2-alpha and cyclooxygenase-2 localize to intracellular membranes of EA.hy.926 endothelial cells that are distinct from the endoplasmic reticulum and the Golgi apparatus. | 2005 Mar |
1 |
| 36 |
15878913 | Arachidonic acid, an omega-6 fatty acid, induces cytoplasmic phospholipase A2 in prostate carcinoma cells. | 2005 Sep |
1 |
| 37 |
15887126 | The role of prostaglandins and other eicosanoids in the gastrointestinal tract. | 2005 May |
1 |
| 38 |
15926604 | COX-2 selective nonsteroidal anti-inflammatory drugs: current status. | 2005 Mar |
1 |
| 39 |
15990700 | COX-2 inhibitors and metabolism of essential fatty acids. | 2005 Jul |
1 |
| 40 |
16154102 | Prostacyclin protects against elevated blood pressure and cardiac fibrosis. | 2005 Sep |
1 |
| 41 |
16213697 | Modification of eicosanoid profile in human blood treated by dual COX/LOX inhibitors. | 2005 Dec |
1 |
| 42 |
14693827 | The eicosanoid cascade: possible role in gliomas and meningiomas. | 2004 Jan |
1 |
| 43 |
14762100 | Cooperation between aspirin-triggered lipoxin and nitric oxide (NO) mediates antiadhesive properties of 2-(Acetyloxy)benzoic acid 3-(nitrooxymethyl)phenyl ester (NCX-4016) (NO-aspirin) on neutrophil-endothelial cell adherence. | 2004 Jun |
1 |
| 44 |
15229941 | Paracrine upregulation of monocyte cyclooxygenase-2 by mediators produced by T lymphocytes: role of interleukin 17 and interferon-gamma. | 2004 Jul |
1 |
| 45 |
15254428 | Eicosanoid metabolism in squamous cell carcinoma cell lines derived from primary and metastatic head and neck cancer and its modulation by celecoxib. | 2004 Sep |
1 |
| 46 |
15301300 | Expression and localization of cyclooxigenases (Cox-1 and Cox-2) in nasal respiratory mucosa. Does Cox-2 play a key role in the immunology of nasal polyps? | 2004 |
2 |
| 47 |
12648159 | Interactions between COX-2 and the renin-angiotensin system in the kidney. | 2003 Apr |
1 |
| 48 |
12795055 | Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis. | 2003 |
1 |
| 49 |
12060588 | Cyclooxygenase-2 products compensate for inhibition of nitric oxide regulation of renal perfusion. | 2002 Jul |
2 |
| 50 |
12086293 | Current perspective on the cardiovascular effects of coxibs. | 2002 |
1 |